Medical

International Expert Team Meets to Finalize First-Ever DM Care Recommendations for Doctors

Myotonic and its international team of clinical care partners just met in Miami to draft consensus-based Care Considerations for doctors, pharmaceutical companies and federal regulators reviewing potential therapies. Read more in this article.

New Findings on Quality of Life in DM2

A new quality of life study found that some DM2 patients are impacted as severely as those with DM1. Read more on the findings here.

Gender Matters in DM1

Dr. Guillaume Bassez and a large team in France and Canada recently published an analysis of gender and its impact on the DM1 phenotype. Read about their findings in this article.

Multi-Disciplinary Approach Needed for Congenital and Childhood DM Care

The results of a new MDF-funded study on the impact of congenital myotonic dystrophy are now available from Dr. Nicholas Johnson of the University of Utah and colleagues. The high frequency of social and cognitive issues in their findings underline the need for a multi-disciplinary approach to care. 

The Impact of Pregnancy on Myotonic Dystrophy: A Registry-Based Study

Many common DM symptoms become more severe during pregnancy, and women with DM have higher than average miscarriage rates, according to a study commissioned by Myotonic that examined data from the Myotonic Dystrophy Family Registry and the National Registry for DM and FSHD. Read a summary of the findings written by Katharine Hagerman, PhD, Research Assistant at Stanford University.

Myotonic Dystrophy Anesthesia Guidelines

Anesthesia raises special risks to those living with myotonic dystrophy (DM), as the disease results in heightened sensitivity to sedatives and analgesics.

Common Symptoms of DM2 and Their Impact on Daily Living

Researchers from the University of Rochester recently published a paper examining the symptoms and impact of myotonic dystrophy type 2 (DM2). They found that the most commonly reported symptoms of DM2 are not, in fact, the ones that have the highest reported impact on daily living.

Benefit/Risk Study Results: Focus on Muscle Weakness

The Myotonic Dystrophy Foundation partnered with Silicon Valley Research Group to develop a survey to better understand how people with DM weigh the benefits of new treatments again the risks. 

Dr. Benedikt Schoser: Focus on the Patient

As a clinician and researcher, Dr. Benedikt Schoser of Ludwig-Maximilians University of Munich, Germany, is focused on how research findings can be translated into improved patient care - and how patient concerns can help guide researchers to new areas of interest.

Healthy Heart Information for American Heart Month

February is American Heart Month, and MDF has partnered with Drs. Katharine Hagerman and Marianne Goodwin to highlight important research on cardiac issues in myotonic dystrophy for our readers

© Myotonic Dystrophy Foundation. All rights reserved.